Panacea Life Sciences Holdings, Inc. (PLSH)
OTCMKTS: PLSH · Delayed Price · USD
0.0911
0.00 (0.00%)
Jul 2, 2024, 3:20 PM EDT - Market closed
Company Description
Panacea Life Sciences Holdings, Inc., operates as a holding company, develops, manufactures, research, produces, and distributes hemp-derived cannabinoid, functional mushroom, Kratom, plant-based ingredients, and nutraceutical products for consumers and pets.
The company also involved in the white label and contract manufacturing sales to other hemp companies, raw material sales, and tolling arrangements.
In addition, it offers natural remedies under the PANA Health, PANA Beauty, PANA Pet, PANA Sport, PANA Pure, and PANA Life brand name.
The company was incorporated in 2008 and is headquartered in Greenwood Village, Colorado.
Panacea Life Sciences Holdings, Inc.
| Country | United States |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 40 |
| CEO | Ms. Leslie A. Buttorff |
Contact Details
Address: 5910 South University Blvd, C18-193 Greenwood Village, Colorado 80121 United States | |
| Phone | 561-455-4822 |
| Website | panacealife.com |
Stock Details
| Ticker Symbol | PLSH |
| Exchange | OTCMKTS |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001552189 |
| CUSIP Number | 69810P109 |
| ISIN Number | US69810P1093 |
| Employer ID | 27-1085858 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Leslie A. Buttorff | Chairman, Chief Executive Officer and Chief Financial Officer |
| Nathan Joel Berman | Secretary, Controller and Principal Accounting Officer |
| Dr. James W. Baumgartner Ph.D. | Chief Science Officer and Quality Control |
| Jordan Buttorff | Chief Information Officer |
| Nicholas J. Cavarra | Senior Vice President of Marketing and Sales |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 11, 2024 | 1-A | Filing |
| May 16, 2024 | 8-K | Current Report |
| May 7, 2024 | 8-K | Current Report |
| May 6, 2024 | 10-Q | Quarterly Report |
| Apr 1, 2024 | 10-K | Annual Report |
| Mar 7, 2024 | 8-K | Current Report |
| Feb 5, 2024 | 8-K | Current Report |
| Dec 8, 2023 | 8-K/A | [Amend] Current report |
| Nov 14, 2023 | 10-Q | Quarterly Report |
| Oct 5, 2023 | 8-K | Current Report |